Steris's revenue for the
three
months ended in Mar. 2026 was $1,588 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $5,936 Mil.
Steris's Revenue per Share for the
three
months ended in Mar. 2026 was $16.14.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $60.18.
Good Sign:
Steris PLC has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Steris was 9.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 9.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Steris's highest 3-Year average Revenue per Share Growth Rate was 189.00% per year. The lowest was -30.90% per year. And the median was 8.00% per year.
Steris (NYSE:STE) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Steris Revenue Related Terms
Steris Revenue Historical Data
* Premium members only.
The historical data trend for Steris's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Steris's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's Revenue distribution charts can be found below:
* The bar in red indicates where Steris's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,936 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris (STE) has a Revenue of $5,936 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Steris and its competitors.
Is Steris' Revenue too high?
Steris' current Revenue is $5,936 Mil. Overall, Steris has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Steris' Revenue compare to ZBH and DXCM?
Steris' Revenue of $5,936 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Steris and its competitors. Steris's current Revenue is $5,936 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Based on GuruFocus' analysis, Steris (STE) is currently considered Modestly Undervalued. The stock's GF Value™ is $269.58, compared to a current price of $216.00 — trading 19.9% below its estimated fair value. The current Revenue is $5,936 Mil. Steris' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Steris (STE), the current Revenue is $5,936 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Steris (STE) Overvalued in 2026?
Based on GuruFocus' analysis, Steris stock appears to be undervalued.
The current stock price of $216.00 is trading 19.9% below its estimated GF Value™ of $269.58.
GuruFocus considers Steris to be Modestly Undervalued.
Key valuation signals for STE:
Revenue: $5,936 Mil
GF Value™: $269.58 vs. price of $216.00 (19.9% below fair value)
No single metric tells the full story. See the STE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
90GF Score
Get the complete analysis for STE
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STE has been successfully added to your 
